C-X-C motif chemokine receptor 7
CXCR7proteinCXCR7 coordinates chemotaxis and platelet-leukocyte interactions during plaque inflammation and early thrombotic response in Type 1 MI.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleChemokine receptor regulating leukocyte recruitment and platelet oxLDL interactions; thromboinflammatory modulation.
Also acts inPlatelet activation
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I36
C — confounder / Type-II58
A — assay feasibility68
E — evidence strength22
T1DI (composite)6
Specificity differential (R−C)-21.5
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(3)
- Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation.Blood · 2022 · PMID 34905596 · doi
- Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology.Cells · 2022 · PMID 35053329 · doi
- Regulation of oxidized platelet lipidome: implications for coronary artery disease.European heart journal · 2017 · PMID 28431006 · doi